Mitochondrial DNA Copy Number Drives the Penetrance of Acute Intermittent Porphyria

• Published in: Life (Basel, Switzerland) Vol. 13; no. 9; p. 1923
• Main Authors: Di Pierro, Elena, Perrone, Miriana, Franco, Milena, Granata, Francesca, Duca, Lorena, Lattuada, Debora, De Luca, Giacomo, Graziadei, Giovanna
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 01.09.2023; MDPI
• Subjects: acute intermittent porphyria; Asymptomatic; Biomarkers; Biosynthesis; Blood cells; Copy number; Copy number variations; Cytochrome; Deoxyribonucleic acid; Development and progression; DNA; Environmental stress; Enzymes; Genes; Genetic aspects; Genetic factors; Genetic testing; Health aspects; heme; Hemoglobin; Hormones; incomplete penetrance; Leukocytes; Medical research; Medicine, Experimental; Metabolism; Mitochondria; mitochondrial biogenesis; Mitochondrial DNA; mtDNA copy number; Mutation; Pain; Pathogenesis; Peripheral blood; PERM1; Phenotypes; Porphyria; Serum levels; Italy; United States > US
• ISSN: 2075-1729; 2075-1729
• DOI: 10.3390/life13091923

No published study has investigated the mitochondrial count in patients suffering from acute intermittent porphyria (AIP). In order to determine whether mitochondrial content can influence the pathogenesis of porphyria, we measured the mitochondrial DNA (mtDNA) copy number in the peripheral blood cells of 34 patients and 37 healthy individuals. We found that all AIP patients had a low number of mitochondria, likely as a result of a protective mechanism against an inherited heme synthesis deficiency. Furthermore, we identified a close correlation between disease penetrance and decreases in the mitochondrial content and serum levels of PERM1, a marker of mitochondrial biogenesis. In a healthy individual, mitochondrial count is usually modulated to fit its ability to respond to various environmental stressors and bioenergetic demands. In AIP patients, coincidentally, the phenotype only manifests in response to endogenous and exogenous triggers factors. Therefore, these new findings suggest that a deficiency in mitochondrial proliferation could affect the individual responsiveness to stimuli, providing a new explanation for the variability in the clinical manifestations of porphyria. However, the metabolic and/or genetic factors responsible for this impairment remain to be identified. In conclusion, both mtDNA copy number per cell and mitochondrial biogenesis seem to play a role in either inhibiting or promoting disease expression. They could serve as two novel biomarkers for porphyria.